# Paul Capital: portfolio, investments and team > Paul Capital is a private equity based in United States. 6 investments on record, latest Feb 2011. Portfolio, stages, co-investors and team. Source: https://millionrounds.com/fund/paul-capital-partners (Millionrounds; every figure on the page links to its filing or article) United States · [Investor](https://millionrounds.com/investors) # Paul Capital No cheque observed since Feb 2011, after 6 earlier cheques, and the website is dead. Dormant New fund $145M, May 2013 Private equity Growth Venture Series A Android Biopharma Life Science Cheques on record **0%** of best year **0** **cheques in 12 months**, 6 on record Since the last cheque **5725** days **00** hrs **00** min **00** sec Median round **$58M** Rounds led **0 of 6** Sole investor **3 rounds** Mostly in **United States, 50%** Pitch Paul Capital ## Paul Capital highlights - 01 6 rounds on record - 02 Mostly Growth and Venture: 67% of its rounds - 03 Sole investor in 3 rounds, median $100M ## What they do > Filed 1 private fund offering with the SEC, the most recent in 2013-05 From their own website - **Type:** Private equity (from a list, unverified) - **Cheque size:** Not stated - **Sectors:** Android Biopharma Life Science - **Based in:** San Francisco, United States - **Cold pitches:** Not stated ## The record Every round we can evidence, newest first **6 appearances** - **2011** 1 round - **Feb** **[Recyclebank](https://millionrounds.com/company/recyclebank)** Series C · US · recyclebank.com **$14M** With 6 others - **2010** 1 round - **Jan** **[Phase III Development](https://millionrounds.com/company/phase-iii-development)** Growth · CA · pehub.com **$100M** Sole investor - **2009** 1 round - **Dec** **[UCB Pharma](https://millionrounds.com/company/ucb-pharma)** Growth · BE · fis.dowjones.com **$100M** Sole investor - **2008** 1 round - **Aug** **[SpePharm](https://millionrounds.com/company/spepharm)** Venture · NL · spepharm.com **$39M** With 2 others - **2006** 1 round - **Nov** **[Acorda Therapeutics](https://millionrounds.com/company/acorda-therapeutics)** Venture · US **$10M** Sole investor - **2005** 1 round - **Jun** **[Verus Pharmaceuticals](https://millionrounds.com/company/verus-pharmaceuticals)** Series A · US **$78M** With 6 others An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor. ## The team Named by the firm itself, on a filing, its Form ADV or its company registration **13 named** BW **Brian W. Sullivan** Executive Officer, Promoter i Filing they signed BT **Bryon T. Sheets** Executive Officer, Promoter i Filing they signed DP **Daniel P. Mulderry** Executive Officer, Promoter i Filing they signed DA **David A. York** Manager of the Manager i Filing they signed DH **David H. De Weese** Executive Officer, Promoter i Filing they signed EL **Elaine L. Small** Executive Officer, Promoter i Filing they signed GR **Guy R. Rico** Executive Officer, Promoter i Filing they signed JD **J. Daniel Townsend** Principal of the Manager i Filing they signed LM **Lisa M. Edgar** Principal of the Manager i Filing they signed PJ **Philip J. Jensen** Executive Officer, Promoter i Filing they signed PS **Philip S. Paul** Manager of the Manager i Filing they signed RC **Randall Clay Schwed** Chief Executive Officer, Chief Financial Officer, President, Chief Compliance Officer, Secretary and Director i Form ADV SH **Simon H. Guenzl** Executive Officer, Promoter i Filing they signed We also hold **21** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them. ## What the register says From the firm's own filings with the SEC, which it must file accurately by law **$521M** assets it manages Oct 2026 **Registered** investment adviser full reporting to the SEC - **Legal name:** 3000 Management, Inc. - **SEC number:** CRD 121168 Funds on its Form ADV **5** private funds, **$558M** in gross assets · filed Mar 2024 - Paul Capital Partners IX, L.P. *Private equity* 104 investors $512M - Paul Capital Partners VIII-C, L.P. *Private equity* 46 investors $19M - Paul Capital Town Street Partners L.P. *Private equity* 2 investors $14M - Paul Capital Partners VIII-A, L.P. *Private equity* 60 investors $10M - Paul Capital Partners VIII-B, L.P. *Private equity* 3 investors $2.2M Who backs their funds ## 1 LP on record in Paul Capital's funds - **Committed:** $50M - **Funds:** 1 - **Vintages:** 2004 The institutions that put money into its funds, which the firm then invests in companies. Source: the pension's own report, latest Jun 2025. - [**California State Teachers Retirement System** 1 fund *$50M*](https://millionrounds.com/fund/california-state-teachers-retirement-system) Fund Vintage Committed Paul Capital VIII-B 2004 $50M New fund on file **$145M** raised in May 2013 From its SEC filing, not a journalist: a firm that has just raised has money to deploy. ## The cheque Growth Venture Series A Median round joined **$58M** the round, not its cheque Alone, median **$100M** Led 0 of 6 rounds **0%** - **Sole investor:** 3 rounds - **Last cheque:** Feb 2011 Rounds by stage said on their site - Growth *2* - Venture *2* - Series A *1* - Series C *1* Cheques by year Led Joined 2005 2011 **Pitching Paul Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque. Add to your CRM *→* ## Mentioned on podcasts Episodes that name Paul Capital in their description, not their title. - [Superclusters](https://millionrounds.com/podcasts/superclusters) 1 Dec 2024 · 43 min Listening to the Heartbeat of the Market | David York | Superclusters | S4E4 With [David York](https://millionrounds.com/person/david-york) Mentions [Hambrecht & Quist](https://millionrounds.com/fund/hambrecht-and-quist)[Paul Capital](https://millionrounds.com/fund/paul-capital-partners)[Top Tier](https://millionrounds.com/fund/top-tier) Apple PodcastsShow page ## Quick answers about Paul Capital ### What does Paul Capital invest in? Paul Capital invests most often at Growth and Venture (67% of the rounds on record), in sectors such as Android, Biopharma and Life Science. ### How active is Paul Capital? 6 investments on record, 0 of them in the last 12 months. The most recent was in Feb 2011. ### How big are Paul Capital's cheques? The median round it joins is $58M. ### Does Paul Capital lead rounds? Rarely, if at all: none of its 6 investments on record names it as the lead. ### Where does Paul Capital invest? Most of the companies it backs are in the United States (50%), Canada (17%) and Belgium (17%). ### Is Paul Capital investing now? It looks quiet: no investment on record since Feb 2011. ### What kind of investor is Paul Capital? Paul Capital is a private equity firm based in San Francisco, United States. ### How much does Paul Capital manage? About $521M, as regulatory assets under management (Oct 2026). ## Raising now? Find the investors who back rounds like yours, and keep every conversation on one fundraising board. Find similar investorsOpen your CRM Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=paul-capital-partners) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=paul-capital-partners)